The aim of the present longitudinal cohort study was to determine whether elevated CRP levels measured in the early stages of COVID-19 were associated, independently from the albumin levels, with higher 14-day mortality in geriatric patients hospitalized for COVID-19. The gene discussed is ALB; the disease is COVID-19.